Another OTC pharma roll up

Cheaper than the last one

I recently wrote up Alliance Pharma (APH), so far the stock has moved up from 37p to 46p (now trading at over 9x adjusted earnings). So I sold about 40% of my position and moved the funds into a similar pharma roll up with lower debt and better organic growth prospects but at a much cheaper valuation of 6-7x adjusted earnings.